APAndré Luiz Rodrigues Palmeira

André Luiz Rodrigues Palmeira

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


André Luiz Rodrigues Palmeira has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Validation of the Quick Dementia Rating System (QDRS): diagnostic properties and cutoff values

    by Joana Emilia Senger, Renata Kochhann, Daniel Arnold, Marco Antonio de Bastiani, Ariele Detogni, Neide Maria Bruscato, Emilio Hideyuki Moriguchi, João Senger, Anelise Vivian Fuhr, André Luiz Rodrigues Palmeira, et al.

    Dementia underdiagnosis persists because lengthy staging tools hinder routine clinical use. The Quick Dementia Rating System (QDRS) offers a brief, informant-based alternative. Objective: This study validates the Brazilian Portuguese QDRS and establishes optimal cutoff values for diagnostic accuracy. Methods: Individuals from primary care and a secondary memory clinic in Southern Brazil were included. Informants completed the QDRS prior to clinical evaluation. All participants underwent comprehensive neurological and neuropsychological assessment, including the Clinical Dementia Rating (CDR), Mini-Mental State Examination (MMSE), and Montreal Cognitive Assessment (MoCa). Psychometric properties (internal consistency and concurrent validity), diagnostic accuracy, and staging agreement between different diagnostic groups and CDR categories were investigated. Results: A total of 180 participants were included in this study (59 cognitively unimpaired, 63 with mild cognitive impairment [MCI], and 58 with dementia). The QDRS demonstrated excellent internal consistency (Cronbach’s α=0.94) and strong concurrent validity with the CDR-Sum of Boxes (p=0.82, p<0.001), MMSE and MoCa scores. Agreement between corresponding QDRS and CDR domains ranged from moderate to good (Intraclass Correlation Coefficient — ICC=0.73–0.89). Diagnostic accuracy for dementia was excellent relative to both clinical diagnosis (cutoff 3.25; Area Under the Curve — AUC=0.98) and CDR staging (cutoff 4.25; AUC=0.97), with sensitivities and specificities exceeding 92%. Staging agreement with the CDR was substantial (weighted Kappa=0.64). Conclusion: The Brazilian Portuguese QDRS is a reliable and efficient instrument for dementia screening and staging. Large-scale testing in clinical practice and population-based research are warranted.

  • Open Access

    Headache in Vale do Taquari: a retrospective study

    by Jesuély Spieckert de Souza, Mariana Cristina Ribeiro, Paula Schmitz Gomes, André Luiz Palmeira, Frederico Orlando Friedrich, Vanise Grassi

    Introduction Primary headaches are highly prevalent neurological disorders and represent a global public health issue, with a significant impact on functionality and quality of life. Despite this, studies indicate that a considerable portion of sufferers, especially those with migraine, remain without a formal diagnosis, which hinders adequate clinical management. In this context, understanding the epidemiological profile at regional levels is essential. Objective Therefore, the aim of this study is to describe the profile of patients presenting with headache complaints at a specialized neurology center in Vale do Taquari (Lajeado/RS), to support healthcare strategies for this population. Methods Observational, descriptive, and retrospective study based on the review of medical records from a specialized clinical center in Vale do Taquari, Rio Grande do Sul. Patients aged 18 years or older, attended for primary headache complaints between August 2017 and February 2024 were included. Sociodemographic, clinical (ICHD-3 diagnosis), and treatment variables were collected and analyzed using descriptive statistics. The project was approved by the Research Ethics Committee. Results The sample consisted of 111 patients, with a mean age of 48 years and a predominance of females (n=91, 82%). Most self-identified as white (n=96, 87%), and (n=18, 35%) had a low level of education (5 to 8 years). The most prevalent diagnosis was migraine without aura (n=54, 48.6%), followed by cervicogenic headache (n=22, 19.8%) and tension-type headache (n=17, 15.3%). Neurological examination abnormalities were detected in some patients, mainly in cranial nerves and sensory function. Magnetic resonance imaging was the most requested imaging exam (n=51, 45.9%). Acute treatment was predominantly monotherapy, with common analgesics being the most prescribed. Prophylaxis was instituted in 74 (66.4%) of cases, mainly with tricyclic antidepressants and beta-blockers. Conclusion This study allowed the characterization of the clinical and sociodemographic profiles of patients presenting with headache complaints at a specialized center in Vale do Taquari, highlighting a predominance of females, a mean age of 48 years, and a higher prevalence of migraine without aura. A high rate of imaging requests was observed, not always aligned with guidelines, as well as predominant use of common analgesics for acute treatment and tricyclic antidepressants and beta-blockers for prophylaxis.

  • Open Access

    The use of angiotensin receptor blockers in dementia prevention

    by Jordana de Araujo Müller, Laura Jacques Giacobe, Vanise Grassi, André Luiz Rodrigues Palmeira

    Alzheimer’s disease (AD) and dementia are preventable and highly prevalent diseases, as is systemic arterial hypertension. Thus, it is speculated that angiotensin receptor blockers (ARBs) may be neuroprotective against AD. Objective: The aim of this study was to evaluate if the use of ARBs confers a neuroprotective effect on AD, through a systematic review. Methods: Studies published on Embase, LILACS, SciELO, and PubMed were evaluated. The selection of the studies included those that evaluated the use of antihypertensive drugs in individuals with a previous diagnosis of mild cognitive impairment. The data were extracted with the Cochrane Effective Practice and Organization of Care (EPOC) form. The risk of bias was evaluated by the EPOC “Risk of bias tool.” Results: A total of 12 articles were identified, and 3 articles were selected. Two of them analyzed the use of ARB/ACEI versus other antihypertensives and the development of dementia. Conclusion: There is a tendency for ARBs to be superior to other antihypertensives in preventing dementia.


  • Open Access

    Chronic insomnia disorder as risk factor for stroke: a systematic review

    by Luiz Augusto Soares Silva, Mateus Molin Do Amaral, Vanise Grassi, André Luiz Rodrigues Palmeira

    Background Stroke is one of the main causes of mortality worldwide. Nonetheless, there are still risk factors that have not been fully elucidated, such as chronic insomnia disorder. Objective To evaluate the association between chronic insomnia disorder and the risk of stroke in adults, through a systematic review. Methods Multiple studies available in the Embase, Lilacs, and Medline platforms were evaluated in English, Spanish, French, and Portuguese. The selection of papers was restricted to those that had investigated the association between chronic insomnia disorder and stroke in adults, regardless of gender or nationality, without a previous history of stroke. The data was extracted with the Cochrane Effective Practice and Organization of Care (EPOC) form. The risk of bias was evaluated by the EPOC Risk of bias tool. Results A total of 138 articles were identified. After a detailed evaluation with the eligibility criteria, four articles were included in the present systematic review. Three of them recognized the association between chronic insomnia disorder and stroke. The comparative analysis was limited, since the studies used distinct insomnia classifications. Regarding the risk of bias, the analysis displayed an important risk in the selection and allocation of participants, besides the use of own insomnia diagnosis criteria, disrespecting chronology and factors indicated by already established classifications. Conclusions There is not enough data to determine that chronic insomnia disorder is a risk factor for stroke. The present study points out the existence of a possible relationship between insomnia disorder and stroke, suggesting that further studies adopt standardized criteria and instruments.